FDA Transparency Has No Clear Path To Releasing Documents - Woodcock
This article was originally published in The Tan Sheet
Executive Summary
The possible release of FDA's voluminous documents is one of the more challenging aspects - both in policies and resources - of the agency's effort to make its operations and decisions more open to the public, FDA's Janet Woodcock says